sellout by board member, page-45

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 45 Last

Share
Profile

Follow
WoodySpoon

9,727 Posts.

2941

17/12/16

18:59

Post #: 21413009
Share

Originally posted by crossyaus ↑

Ok fair enough.

I've been out of this for a long time, and won't be back in (not for any money). This puppy has had a great run, but in my opinion reality is starting to catch up with it.

Despite all the ramping on here, if you sit down an read all the RAP market announcements right from listing and try to be as objective as possible, nothing much has really changed about the tech since it first listed.

Sure, it is now moving towards FDA approval (which is still a big IF), but the basic premise and promise of the technology hasn't changed much since listing (note it listed at 2c). As someone who has played in the biotech space for a while, FDA approval can take a very long time, and is by no means guaranteed. I've seen stocks aim to recruit certain numbers of trial patients in the USA, but then never reach the numbers, or it has then taken 12 months to actually get the required number to even commence a trial. Then you go through all the trials and review by the FDA etc. The process can take years. I notice RAP's recent announcement about the FDA trial did not include any timeframe - that's because they don't know how long it will take. I strongly urge anyone investing on the assumption that this trial will be done within 6 months to just spend an hour or so looking at price sensitive announcements regarding FDA trials from any other speccie biotech listed on the asx and just take a look how long it actually takes.

If anyone wants to see a great example of a hyped biotech stock that was going to be the next big thing pending FDA approval which everyone was saying was a sure thing (but then didn't happen), just take at look at the history of PXS.

Combine all the above with Uniquest having dumped everything and now a director selling everything they possibly could (without an official explanation to the market) - this is a high risk investment which is getting closer to coming back to earth each day.

IF this puppy does go down hard, you can't say the warning signs weren't there.

Expand

Wow, you must really want in on Monday, huh?
Many biotechs want to put untested things into people's bodies. Not a lot of people are going to say yes to that unless it's a last resort.
We want people to cough once on a phone. You think that's going to be a hard sell?

RAP Price at posting: 30.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

What's causing the cost-of-living crisis, and how to navigate it

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war